Advertisement

Organisation › Details
American Society of Hematology (ASH)
![]() |
Industry | medicine |
![]() |
Region | Washington, D.C. |
Country | United States (USA) | |
Street | 1900 M Street NW, Suite 200 | |
City | 20036 Washington, DC | |
Tel | +1-202-776-0544 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Record changed: 2019-04-28 |
Advertisement

More documents for American Society of Hematology (ASH)
- [1] Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia". Breda & Ghent....
- [2] Argen-X N.V. (Argenx). (12/11/17). "Press Release: Argenx to Provide Updates on Phase 1/2 Clinical Trials of ARGX-110 in Acute Myeloid Leukemia and Cutaneous T-Cell Lymphoma during American Society of Hematology Annual Meeting". Breda & Ghent....
- [3] CRISPR Therapeutics AG. (12/10/17). "Press Release: CRISPR Therapeutics Announces Oral Presentation of New Data on CTX001, a CRISPR Gene-Edited Therapy for ß-Thalassemia and Sickle Cell Disease, at the ASH Annual Meeting". Zug & Cambridge, MA....
- [4] Affimed N.V.. (12/11/17). "Press Release: Affimed Presents Data from Phase 1b Combination Study of AFM13 with Pembrolizumab at ASH". Heidelberg....
- [5] MorphoSys AG. (12/6/16). "Press Release: MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 2016 Conference"....
- [6] MorphoSys AG. (12/6/16). "Press Release: MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016"....
- [7] Kymab Group Ltd.. (12/5/16). "Press Release: Antibody Shows Dramatic Post-transplant Benefit"....
- [8] Affimed N.V.. (11/8/16). "Press Release: Affimed to Present Preclinical Data on Bi- and Trispecific Immune Cell Engagers at ASH". Heidelberg....
- [9] Roche. (11/3/16). "Press Release: Roche Showcases New Clinical Data across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting". Basel....
- [10] Medigene AG. (12/8/15). "Press Release: Promising Data from Phase I/II IIT and Compassionate Use Programme with Dendritic Cell Vaccines in AML Presented at ASH Annual Meeting 2015". Martinsried....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top